Stay updated on Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    A new revision (v3.4.2) was added to the study record history; the previous revision (v3.4.1) was removed along with its associated notice.
    Difference
    0.8%
    Check dated 2026-02-11T09:19:45.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    A government funding status notice was added and the page revision label updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2026-02-04T05:33:50.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Glossary is now shown and the page uses green and red highlights to indicate additions and deletions, with the revision updated to v3.4.0 (No FEAR Act Data reflected in the UI). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    1%
    Check dated 2026-01-28T03:47:30.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Revision history shows an added Revision: v3.3.4 and removal of Revision: v3.3.3, reflecting an internal update to the site’s version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:16:18.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    A new Revision: v3.3.3 entry appeared and the references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the page footer. These are minor maintenance updates that do not affect study details or user-facing content, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:40:38.000Z thumbnail image
  9. Check
    102 days ago
    Change Detected
    Summary
    The history shows a new revision v3.3.2 and removal of v3.2.0, indicating administrative updates to the record rather than changes to trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:51:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cisplatin+IMRT in Head & Neck Cancer Clinical Trial page.